Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000941267 | SCV001087150 | likely benign | not provided | 2024-03-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000941267 | SCV001981946 | uncertain significance | not provided | 2024-07-03 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001275930 | SCV001461610 | uncertain significance | Usher syndrome type 1 | 2020-04-15 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004543522 | SCV004773180 | uncertain significance | CDH23-related disorder | 2023-10-27 | no assertion criteria provided | clinical testing | The CDH23 c.1750C>T variant is predicted to result in the amino acid substitution p.Arg584Trp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0080% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-73437448-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |